Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma

Clinical trial NCT00911196 · COMPLETED

Trial details

NCT number: NCT00911196
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatocellular Carcinoma

Start date: 2008-11-01
Primary completion: 2009-03-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.